Michael B. Keller

420 total citations
23 papers, 283 citations indexed

About

Michael B. Keller is a scholar working on Surgery, Transplantation and Oncology. According to data from OpenAlex, Michael B. Keller has authored 23 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 13 papers in Transplantation and 6 papers in Oncology. Recurrent topics in Michael B. Keller's work include Transplantation: Methods and Outcomes (15 papers), Renal Transplantation Outcomes and Treatments (13 papers) and Coronary Interventions and Diagnostics (6 papers). Michael B. Keller is often cited by papers focused on Transplantation: Methods and Outcomes (15 papers), Renal Transplantation Outcomes and Treatments (13 papers) and Coronary Interventions and Diagnostics (6 papers). Michael B. Keller collaborates with scholars based in United States, Italy and India. Michael B. Keller's co-authors include Steven R. Lowenstein, Lowell F. Satler, Kenneth M. Kent, Martin B. Leon, Gary S. Mintz, Sean Agbor-Enoh, Augusto D. Pichard, Pali D. Shah, Jeffrey J. Popma and Moon Kyoo Jang and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, The American Journal of Cardiology and European Respiratory Journal.

In The Last Decade

Michael B. Keller

20 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael B. Keller United States 9 226 86 83 68 55 23 283
Gregory Muehlebach United States 10 225 1.0× 33 0.4× 203 2.4× 55 0.8× 100 1.8× 15 355
V. Gómez Dos Santos Spain 10 158 0.7× 36 0.4× 11 0.1× 19 0.3× 127 2.3× 66 312
Katsunori Nishikawa Japan 12 236 1.0× 20 0.2× 17 0.2× 15 0.2× 176 3.2× 44 320
S.R. Harries United Kingdom 8 167 0.7× 16 0.2× 20 0.2× 18 0.3× 58 1.1× 12 279
Hoang M. Lai United States 13 121 0.5× 7 0.1× 206 2.5× 86 1.3× 36 0.7× 33 364
F. Meister Germany 10 154 0.7× 27 0.3× 12 0.1× 12 0.2× 63 1.1× 24 258
M. Mora Spain 4 268 1.2× 5 0.1× 192 2.3× 29 0.4× 121 2.2× 18 361
Emir Karaçağlar Türkiye 7 40 0.2× 6 0.1× 105 1.3× 11 0.2× 82 1.5× 33 170
Joshua S. Jolissaint United States 11 190 0.8× 3 0.0× 46 0.6× 14 0.2× 78 1.4× 28 270
Witold Chudziński Poland 8 112 0.5× 15 0.2× 21 0.3× 11 0.2× 102 1.9× 29 261

Countries citing papers authored by Michael B. Keller

Since Specialization
Citations

This map shows the geographic impact of Michael B. Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael B. Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael B. Keller more than expected).

Fields of papers citing papers by Michael B. Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael B. Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael B. Keller. The network helps show where Michael B. Keller may publish in the future.

Co-authorship network of co-authors of Michael B. Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Michael B. Keller. A scholar is included among the top collaborators of Michael B. Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael B. Keller. Michael B. Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kong, Heidi H., Helen Luikart, T. Intrieri, et al.. (2025). Levels of Cell-free DNA at the Diagnosis of Antibody-mediated Rejection Predict Poor Outcomes in Lung Transplant Recipients. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A3341–A3341.
2.
Sun, Junfeng, Pali D. Shah, Jeffrey B. Matthews, et al.. (2025). Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunction. The Journal of Heart and Lung Transplantation. 44(11). 1766–1773.
3.
Keller, Michael B., David Newman, Pali D. Shah, et al.. (2025). Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure. The Journal of Heart and Lung Transplantation. 44(10). 1535–1542. 2 indexed citations
4.
Keller, Michael B., Hyesik Kong, Pali D. Shah, et al.. (2025). Early Post-Transplant Recipient Tissue Injury Predicts Allograft Function, Rejection, and Survival in Lung Transplant Recipients, Evidence from Cell-free DNA. European Respiratory Journal. 2402537–2402537. 2 indexed citations
5.
Keller, Michael B., Xin Tian, Moon Kyoo Jang, et al.. (2024). Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 209(10). 1238–1245. 10 indexed citations
6.
Keller, Michael B., Hyesik Kong, T. Andargie, et al.. (2024). Association Between De Novo Donor Specific Antibodies and Baseline Lung Allograft Dysfunction. A1194–A1194.
7.
Keller, Michael B., David Newman, Pali D. Shah, et al.. (2024). Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease. The Journal of Heart and Lung Transplantation. 43(9). 1374–1382. 4 indexed citations
8.
Keller, Michael B., Junfeng Sun, Pali D. Shah, et al.. (2024). Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation Is Associated With an Increased Risk of Death: Results From a Multicenter Cohort Study. Transplantation Direct. 10(7). e1669–e1669. 8 indexed citations
9.
Keller, Michael B., T. Andargie, & Sean Agbor-Enoh. (2023). Biomarkers in the Management of the Lung Transplant Allograft: A Focus on Donor-derived Cell-free DNA. 7(2). 1–17. 1 indexed citations
10.
Keller, Michael B., Xin Tian, Moon Kyoo Jang, et al.. (2023). Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejection. The Journal of Heart and Lung Transplantation. 43(4). 563–570. 3 indexed citations
11.
Yek, Christina, Jing Wang, Jonathan Fintzi, et al.. (2023). Impact of Surge Strain and Pandemic Progression on Prognostication by an Established COVID-19–Specific Severity Score. Critical Care Explorations. 5(12). e1021–e1021. 3 indexed citations
12.
Keller, Michael B., Kai Yu, Moon Kyoo Jang, et al.. (2022). Comparison of donor-derived cell-free DNA between single versus double lung transplant recipients. American Journal of Transplantation. 22(10). 2451–2457. 25 indexed citations
13.
Jang, Moon Kyoo, Ilker Tunc, Gerald J. Berry, et al.. (2021). Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study. The Journal of Heart and Lung Transplantation. 40(8). 822–830. 56 indexed citations
14.
Keller, Michael B. & Steven R. Lowenstein. (2002). Epidemiology of Asthma. Seminars in Respiratory and Critical Care Medicine. 23(4). 317–330. 26 indexed citations
15.
Popma, Jeffrey J., Alexandra J. Lansky, Wanlin Yeh, et al.. (1997). Reliability of the Quantitative Angiographic Measurements in the New Approaches to Coronary Intervention (NACI) Registry: A Comparison of Clinical Site and Repeated Angiographic Core Laboratory Readings. The American Journal of Cardiology. 80(10). 19K–25K. 30 indexed citations
16.
Matar, Fadi, Gary S. Mintz, Andrew Farb, et al.. (1994). The contribution of tissue removal to lumen improvement after directional coronary atherectomy. The American Journal of Cardiology. 74(7). 647–650. 40 indexed citations
17.
Hong, Mun K., Jeffrey J. Popma, Augusto D. Pichard, et al.. (1994). Clinical significance of distal embolization after transluminal extraction atherectomy in diffusely diseased saphenous vein grafts. American Heart Journal. 127(6). 1496–1503. 34 indexed citations
18.
Popma, Jeffrey J., Kenneth M. Kent, Lowell F. Satler, et al.. (1993). Impact of directional atherectomy on adjacent branch vessels. The American Journal of Cardiology. 72(3). 351–353. 6 indexed citations
19.
Popma, Jeffrey J., Martin B. Leon, Kenneth M. Kent, et al.. (1993). Comparison of results of rotational coronary atherectomy in three age groups (<70, 70 to 79 and ≥80 years). The American Journal of Cardiology. 71(10). 862–864. 12 indexed citations
20.
Potkin, Benjamin N., Gary S. Mintz, Augusto D. Pichard, et al.. (1992). Late, out-of-laboratory, abrupt closure after angiographically successful directional coronary atherectomy. The American Journal of Cardiology. 69(3). 263–265. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026